纳米药物载体介导的联合给药逆转肿瘤多药耐药的研究进展(4)
[ 5 ] MARKMAN JL，REKECHENETSKIY A，HOLLER E，et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance[J]. Adv Drug Deliv Rev，2013，65(13/14)：1866-1879.
[ 6 ] SARASWATHY M，GONG S. Different strategies to overcome multidrug resistance in cancer[J]. Biotechnol Adv，2013，31(8)：1397-1407.
[ 7 ] HU CMJ，ZHANG LF. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer[J]. Biochem Pharmacol，2012，83(8)：1104-1111.
, http://www.100md.com
[ 8 ] GAO ZB，ZHANG LN，SUN YJ. Nanotechnology applied to overcome tumor drug resistance[J]. J Control Release，2012，162(1)：45-55.
[ 9 ] FRIBERG S，NYSTR?M AM. Nanomedicine：will it offer possibilities to overcome multiple drug resistance in cancer[J]. J Nanobiotech，2016，14(1)：1-17.
[10] KYDD J，JADIA R，VELPURISIVA P，et al. Targeting strategies for the combination treatment of cancer using drug delivery systems[J]. Pharmaceutics，2017.DOI：10. 3390/pharmaceutics9040046.
, http://www.100md.com
[11] YANG X，YI C，LUO N，et al. Nanomedicine to overcome cancer multidrug resistance[J]. Curr Drug Metab，2014，15(6)：632-649.
[12] SHI CH，ZHANG ZQ，SHI JX，et al. Co-delivery of doce- taxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance[J]. Int J Pharm，2015，495(2)：932-939.
[13] ABOUZEID AH，PATEL NR，TORCHILIN VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer[J]. Int J Pharm，2014，464(1/2)：178-184.
, http://www.100md.com
[14] TANG Y，SOROUSH F，TONG ZH，et al. Targeted multidrug delivery system to overcome chemoresistance in breast cancer[J]. Int J Nanomed，2017.DOI：10.2147/IJN.S124770.
[15] ZENG YP，YANG ZY，LI H，et al. Multifunctional nanographene oxide for targeted gene-mediated thermochemotherapy of drug-resistant tumor[J]. Sci Rep，2017.DOI：10.1038/srep43506.
[16] WANG H，AGARWAL P，ZHAO ST，et al. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127，PLGA，and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells[J]. Biomaterials，2015.DOI：10.1016/j.biomaterials. 2015.08.048.
, http://www.100md.com
[17] LIU B，HAN L，LIU JY，et al. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer[J]. Int J Nanomed，2017.DOI：10.2147/IJN.S115136.
[18] SHAO ZY，SAHO JY，TAN BX，et al. Targeted lung cancer therapy：preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S77837., 百拇医药(曹晓孚 孟路华 刘振 冯蕾 赵艳艳 李兰芳 闫春章)
[ 6 ] SARASWATHY M，GONG S. Different strategies to overcome multidrug resistance in cancer[J]. Biotechnol Adv，2013，31(8)：1397-1407.
[ 7 ] HU CMJ，ZHANG LF. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer[J]. Biochem Pharmacol，2012，83(8)：1104-1111.
, http://www.100md.com
[ 8 ] GAO ZB，ZHANG LN，SUN YJ. Nanotechnology applied to overcome tumor drug resistance[J]. J Control Release，2012，162(1)：45-55.
[ 9 ] FRIBERG S，NYSTR?M AM. Nanomedicine：will it offer possibilities to overcome multiple drug resistance in cancer[J]. J Nanobiotech，2016，14(1)：1-17.
[10] KYDD J，JADIA R，VELPURISIVA P，et al. Targeting strategies for the combination treatment of cancer using drug delivery systems[J]. Pharmaceutics，2017.DOI：10. 3390/pharmaceutics9040046.
, http://www.100md.com
[11] YANG X，YI C，LUO N，et al. Nanomedicine to overcome cancer multidrug resistance[J]. Curr Drug Metab，2014，15(6)：632-649.
[12] SHI CH，ZHANG ZQ，SHI JX，et al. Co-delivery of doce- taxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance[J]. Int J Pharm，2015，495(2)：932-939.
[13] ABOUZEID AH，PATEL NR，TORCHILIN VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer[J]. Int J Pharm，2014，464(1/2)：178-184.
, http://www.100md.com
[14] TANG Y，SOROUSH F，TONG ZH，et al. Targeted multidrug delivery system to overcome chemoresistance in breast cancer[J]. Int J Nanomed，2017.DOI：10.2147/IJN.S124770.
[15] ZENG YP，YANG ZY，LI H，et al. Multifunctional nanographene oxide for targeted gene-mediated thermochemotherapy of drug-resistant tumor[J]. Sci Rep，2017.DOI：10.1038/srep43506.
[16] WANG H，AGARWAL P，ZHAO ST，et al. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127，PLGA，and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells[J]. Biomaterials，2015.DOI：10.1016/j.biomaterials. 2015.08.048.
, http://www.100md.com
[17] LIU B，HAN L，LIU JY，et al. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer[J]. Int J Nanomed，2017.DOI：10.2147/IJN.S115136.
[18] SHAO ZY，SAHO JY，TAN BX，et al. Targeted lung cancer therapy：preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA[J]. Int J Nanomed，2015.DOI：10.2147/IJN.S77837., 百拇医药(曹晓孚 孟路华 刘振 冯蕾 赵艳艳 李兰芳 闫春章)